文献速递甲状腺与颈部外科

慢性肾病对原发性甲状旁腺功能亢进症甲状旁腺切除术中甲状旁腺激素监测的影响

Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.
PubMed 文献 · Surgery · 2017-11-08

单中心回顾性队列研究纳入964例原发性甲状旁腺功能亢进症行甲状旁腺切除术患者,其中235例合并慢性肾病。两组术中甲状旁腺激素降解动力学无显著差异,术后15分钟甲状旁腺激素处于正常范围的比例及持续性疾病发生率均相似。

要点

  • 合并慢性肾病患者术中甲状旁腺激素降解动力学与肾功能正常者相似。
  • 合并慢性肾病患者术后15分钟甲状旁腺激素正常范围比例与肾功能正常者相当。
  • 预测治愈的术中甲状旁腺激素标准对合并慢性肾病患者应同样适用。

核心结论

  • 合并慢性肾病的原发性甲状旁腺功能亢进症患者行甲状旁腺切除术时,术中甲状旁腺激素降解动力学与肾功能正常者相似,预测治愈的术中甲状旁腺激素标准应相似。

研究设计与样本

  • 单中心回顾性队列研究,连续纳入964例原发性甲状旁腺功能亢进症行甲状旁腺切除术患者。
  • 按肾功能分层:正常肾功能为肾小球滤过率≥60 mL/min/1.73 m2,慢性肾病为肾小球滤过率15-60 mL/min/1.73 m2。

主要发现

  • 慢性肾病患者235例(24.4%),肾功能正常者729例(75.6%)。
  • 慢性肾病组术前血清甲状旁腺激素中位数更高(125 vs 114 pg/mL;P < .001)。
  • 术中甲状旁腺激素中位数两组相似:基线(190 vs 189;P=.232)、5分钟(51 vs 47;P = .667)、10分钟(37 vs 35;P=.626)、切除后15分钟(28 vs 27;P=.539)。
  • 基线至切除后15分钟甲状旁腺激素降解斜率两组无显著差异(-21.02 vs -20.83;P=.957)。
  • 切除后15分钟甲状旁腺激素处于正常范围(12 - 65 pg/mL)的比例两组相似(81% vs 82%;P=.906),持续性疾病发生率相似(3.4% vs 3.4%;P=.985)。

关键数值与推荐

  • 慢性肾病定义为肾小球滤过率15-60 mL/min/1.73 m2,正常肾功能定义为肾小球滤过率≥60 mL/min/1.73 m2。
  • 术中甲状旁腺激素正常范围参考值为12 - 65 pg/mL。
  • 预测治愈的术中甲状旁腺激素标准对合并慢性肾病患者应与肾功能正常者相似。

临床怎么用

  • 合并慢性肾病的原发性甲状旁腺功能亢进症患者行甲状旁腺切除术时,可按肾功能正常者的术中甲状旁腺激素标准判断治愈。
  • 术前甲状旁腺激素水平较高不应单独作为调整术中监测判读标准的依据。

局限性

  • 单中心回顾性队列设计,可能存在选择偏倚与资料偏倚。
  • 慢性肾病组样本量小于肾功能正常组,亚组分析效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The influence of chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism has not been well-established. We hypothesize that chronic kidney disease influences intraoperative parathyroid hormone degradation kinetics during parathyroidectomy. METHODS: This is a single institution retrospective cohort study of consecutive patients with primary hyperparathyroidism underdoing parathyroidectomy. Patients were stratified according to normal kidney function (glomerular filtration rates ≥60 mL/min/1.73 m2 or presence of chronic kidney disease (glomerular filtration rates 15 - 60 mL/min/1.73 m2). Demographics, laboratory data, operative findings, and intraoperative parathyroid hormone data were compared between groups. RESULTS: Of the 964 study patients, 235 had chronic kidney disease (24.4%), while 729 (75.6%) had normal kidney function. The chronic kidney disease population had a greater median preoperative serum parathyroid hormone (PTH) (125 vs 114 pg/mL; P < .001), but similar median intraoperative parathyroid hormone levels (chronic kidney disease versus normal): baseline (190 vs 189; P=.232), 5 minutes (51 vs 47; P = .667), 10 minutes (37 vs 35; P=.626), and at 15 minutes postexcision (28 vs 27; P=.539). There was no significant difference in the kinetics of the intraoperative parathyroid hormone degradation slope from the baseline to the 15-minute postexcision levels comparing chronic kidney disease with normal kidney function (-21.02 vs -20.83; P=.957). Patients with chronic kidney disease had 15-minute postexcision intraoperative parathyroid hormone levels within the normal range (12 - 65 pg/mL) as frequently as patients with normal kidney function (81% vs 82%; P=.906) and had similar rates of persistent disease (3.4% vs 3.4%; P=.985). CONCLUSION: Patients with chronic kidney disease undergoing parathyroidectomy for primary hyperparathyroidism have similar intraoperative parathyroid hormone degradation kinetics, and the intraoperative parathyroid hormone criteria used to predict cure should be similar to those with normal kidney function.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Sunkara B, Cohen MS, Miller BS, et al. Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism. Surgery. 2017. PMID: 29128188. doi:10.1016/j.surg.2017.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。